Pharmaceutical

Palforzia’s peanut allergy treatment use in Europe expanded to toddlers

The EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.

Jan 10, 2025 - 06:00
Palforzia’s peanut allergy treatment use in Europe expanded to toddlers
The EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.
Read the original article

Tags:

Previous Article

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate  

Next Article

Aspect Biosystems secures $115m to develop tissue therapeutics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Rolling back SNAP benefits puts millions of children at risk of hunger and long-term health consequences

Opinion: Rolling back SNAP benefits puts millions of ch...

Mar 28, 2023

STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid program pauses on digital therapeutics

STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid p...

Jun 10, 2023

STAT+: Novartis reportedly decides to pass on Cytokinetics

STAT+: Novartis reportedly decides to pass on Cytokinetics

Jan 16, 2024